Danaher Approves $0.40 Dividend and $9.9B Masimo Acquisition at $180
Danaher Corporation’s Board approved a $0.40 per share cash dividend to be paid April 24, 2026, to shareholders of record on March 27, 2026. Danaher agreed to acquire Masimo for $180 per share in cash, valuing the deal at $9.9 billion and equating to about 18x 2027 EBITDA (15x including synergies).
1. Quarterly Cash Dividend
Danaher’s Board of Directors approved a regular quarterly cash dividend of $0.40 per share, payable April 24, 2026, to holders of record on March 27, 2026, reinforcing its commitment to shareholder returns.
2. Masimo Acquisition Terms
Danaher entered a definitive agreement to acquire all outstanding Masimo common stock for $180 per share in cash, representing an enterprise value of approximately $9.9 billion including assumed indebtedness and net acquired cash.
3. Strategic Impact on Diagnostics Segment
Upon closing, Masimo will operate as a standalone business within Danaher’s Diagnostics segment alongside Radiometer, Leica Biosystems, Cepheid, and Beckman Coulter, with anticipated high-single-digit core revenue growth accelerating overall segment expansion.